???pagination.result.count???
???pagination.result.page???
1
Understanding cornea epithelial stem cells and stem cell deficiency: Lessons learned using vertebrate model systems. , Adil MT, Henry JJ ., Genesis. February 1, 2021; 59 (1-2): e23411.
A novel lineage of candidate pheromone receptors for sex communication in moths. , Bastin-Héline L, de Fouchier A, Cao S, Koutroumpa F, Caballero-Vidal G, Robakiewicz S, Monsempes C, François MC, Ribeyre T, Maria A, Chertemps T, de Cian A, Walker WB, Wang G, Jacquin-Joly E, Montagné N., Elife. December 10, 2019; 8
Proliferative regulation of alveolar epithelial type 2 progenitor cells by human Scnn1d gene. , Zhao R, Ali G, Chang J, Komatsu S, Tsukasaki Y, Nie HG, Chang Y, Zhang M, Liu Y , Jain K, Jung BG, Samten B, Jiang D, Liang J, Ikebe M, Matthay MA, Ji HL., Theranostics. October 18, 2019; 9 (26): 8155-8170.
Proceeding From in vivo Functions of Pheromone Receptors: Peripheral-Coding Perception of Pheromones From Three Closely Related Species, Helicoverpa armigera, H. assulta, and Heliothis virescens. , Wang B, Liu Y , Wang GR., Front Physiol. January 1, 2018; 9 1188.
Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors. , Vuille-dit-Bille RN, Camargo SM, Emmenegger L, Sasse T, Kummer E, Jando J, Hamie QM, Meier CF, Hunziker S, Forras-Kaufmann Z, Kuyumcu S, Fox M, Schwizer W, Fried M, Lindenmeyer M, Götze O, Verrey F., Amino Acids. April 1, 2015; 47 (4): 693-705.
Systematic discovery of nonobvious human disease models through orthologous phenotypes. , McGary KL, Park TJ, Woods JO, Cha HJ, Wallingford JB , Marcotte EM ., Proc Natl Acad Sci U S A. April 6, 2010; 107 (14): 6544-9.
Mammalian AT2 receptors expressed in Xenopus laevis oocytes couple to endogenous chloride channels and stimulate germinal vesicle break down. , Reyes R, Pulakat L, Miledi R , Martínez-Torres A., Cell Physiol Biochem. January 1, 2009; 24 (1-2): 45-52.
Role of Phe308 in the seventh transmembrane domain of the AT2 receptor in ligand binding and signaling. , Pulakat L, Mandavia CH, Gavini N., Biochem Biophys Res Commun. July 9, 2004; 319 (4): 1138-43.
Identification of the region of AT2 receptor needed for inhibition of the AT1 receptor-mediated inositol 1,4,5-triphosphate generation. , Kumar V , Knowle D, Gavini N, Pulakat L., FEBS Lett. December 18, 2002; 532 (3): 379-86.
The application of high density microarray for analysis of mitogenic signaling and cell-cycle in the adrenal. , Wang C , Francis R, Harirchian S, Batlle D, Mayhew B, Bassett M, Rainey WE, Pestell RG., Endocr Res. November 1, 2000; 26 (4): 807-23.
Identification of an interaction between the angiotensin II receptor sub-type AT2 and the ErbB3 receptor, a member of the epidermal growth factor receptor family. , Knowle D, Ahmed S, Pulakat L., Regul Pept. February 8, 2000; 87 (1-3): 73-82.
Role of Arg182 in the second extracellular loop of angiotensin II receptor AT2 in ligand binding. , Kurfis J, Knowle D, Pulakat L., Biochem Biophys Res Commun. October 5, 1999; 263 (3): 816-9.
Role of the His273 located in the sixth transmembrane domain of the angiotensin II receptor subtype AT2 in ligand-receptor interaction. , Turner CA, Cooper S, Pulakat L., Biochem Biophys Res Commun. April 21, 1999; 257 (3): 704-7.
Role of the third intracellular loop of the angiotensin II receptor subtype AT2 in ligand-receptor interaction. , Dittus J, Cooper S, Obermair G, Pulakat L, Obermeir G., FEBS Lett. February 19, 1999; 445 (1): 23-6.
Angiotensin II type 1 receptor-mediated inhibition of K+ channel subunit kv2.2 in brain stem and hypothalamic neurons. , Gelband CH, Warth JD, Mason HS, Zhu M, Moore JM, Kenyon JL, Horowitz B, Sumners C., Circ Res. February 19, 1999; 84 (3): 352-9.
Functional expression of sperm angiotensin II type I receptor in Xenopus oocyte: modulation of a sperm Ca2+-activated K+ channel. , So SC, Wu WL, Grima J, Leung PS, Chung YW, Cheng CY, Wong PY, Yan YC, Chan HC., Biochim Biophys Acta. December 9, 1998; 1415 (1): 261-5.
Mutant Vg1 ligands disrupt endoderm and mesoderm formation in Xenopus embryos. , Joseph EM , Melton DA ., Development. July 1, 1998; 125 (14): 2677-85.
A Xenopus homologue of aml-1 reveals unexpected patterning mechanisms leading to the formation of embryonic blood. , Tracey WD, Pepling ME, Horb ME , Thomsen GH , Gergen JP., Development. April 1, 1998; 125 (8): 1371-80.
Shared determinants of receptor binding for subtype selective, and dual endothelin-angiotensin antagonists on the AT1 angiotensin II receptor. , Dascal D, Nirula V, Lawus K, Yoo SE, Walsh TF, Sandberg K., FEBS Lett. February 13, 1998; 423 (1): 15-8.
Role of Lys215 located in the fifth transmembrane domain of the AT2 receptor in ligand-receptor interaction. , Pulakat L, Tadessee AS, Dittus JJ, Gavini N., Regul Pept. January 2, 1998; 73 (1): 51-7.
Xnr4: a Xenopus nodal-related gene expressed in the Spemann organizer. , Joseph EM , Melton DA ., Dev Biol. April 15, 1997; 184 (2): 367-72.
Angiotensin II activation of cyclin D1-dependent kinase activity. , Watanabe G, Lee RJ, Albanese C, Rainey WE, Batlle D, Pestell RG., J Biol Chem. September 13, 1996; 271 (37): 22570-7.
Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor. , Thomsen GH ., Development. August 1, 1996; 122 (8): 2359-66.
Atypical (non- AT1, non- AT2) angiotensin receptors. , Smith RD ., Adv Exp Med Biol. January 1, 1996; 396 237-45.
Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor. , Perlman S, Schambye HT, Rivero RA, Greenlee WJ, Hjorth SA, Schwartz TW., J Biol Chem. January 27, 1995; 270 (4): 1493-6.
Mutations in transmembrane segment VII of the AT1 receptor differentiate between closely related insurmountable and competitive angiotensin antagonists. , Schambye HT, von Wijk B, Hjorth SA, Wienen W, Entzeroth M, Bergsma DJ, Schwartz TW., Br J Pharmacol. October 1, 1994; 113 (2): 331-3.
Isolation and characterization of two alternatively spliced complementary DNAs encoding a Xenopus laevis angiotensin II receptor. , Nishimatsu S, Koyasu N, Sugaya T, Ohnishi J, Yamagishi T, Murakami K, Miyazaki H., Biochim Biophys Acta. August 2, 1994; 1218 (3): 401-7.
Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors. , Schambye HT, Hjorth SA, Bergsma DJ, Sathe G, Schwartz TW., Proc Natl Acad Sci U S A. July 19, 1994; 91 (15): 7046-50.
Properties of angiotensin II receptors in glial cells from the adult corpus callosum. , Matute C, Pulakat L, Río C, Valcárcel C, Miledi R ., Proc Natl Acad Sci U S A. April 26, 1994; 91 (9): 3774-8.
Characterization of a functional angiotensin II receptor in Xenopus laevis heart. , Aiyar N, Baker E, Pullen M, Nuthulaganti P, Bergsma DJ, Kumar C, Nambi P., Pharmacology. April 1, 1994; 48 (4): 242-9.
Isolation and expression of a novel angiotensin II receptor from Xenopus laevis heart. , Bergsma DJ, Ellis C, Nuthulaganti PR, Nambi P, Scaife K, Kumar C, Aiyar N., Mol Pharmacol. August 1, 1993; 44 (2): 277-84.
Molecular cloning, sequencing and functional expression of an amphibian angiotensin II receptor. , Ji H, Sandberg K, Zhang Y , Catt KJ., Biochem Biophys Res Commun. July 30, 1993; 194 (2): 756-62.
Molecular cloning and characterization of the angiotensin receptor subtype in porcine aortic smooth muscle. , Itazaki K, Shigeri Y, Fujimoto M., Eur J Pharmacol. April 15, 1993; 245 (2): 147-56.
Cloning and expression of a novel angiotensin II receptor subtype. , Sandberg K, Ji H, Clark AJ, Shapira H, Catt KJ., J Biol Chem. May 15, 1992; 267 (14): 9455-8.
Expression of GATA-binding proteins during embryonic development in Xenopus laevis. , Zon LI , Mather C, Burgess S, Bolce ME, Harland RM , Orkin SH., Proc Natl Acad Sci U S A. December 1, 1991; 88 (23): 10642-6.
Amphibian myocardial angiotensin II receptors are distinct from mammalian AT1 and AT2 receptor subtypes. , Sandberg K, Ji H, Millan MA, Catt KJ., FEBS Lett. June 24, 1991; 284 (2): 281-4.
Novel angiotensin II antagonists distinguish amphibian from mammalian angiotensin II receptors expressed in Xenopus laevis oocytes. , Ji H, Sandberg K, Catt KJ., Mol Pharmacol. February 1, 1991; 39 (2): 120-3.